Abstract: Methods and kits for diagnosis, prognosis and treatment of metastatic tumors are provided where the metastatic tumor is characterized by changes in expression of +++, ++ and/or 11a variants of Mena.
Type:
Application
Filed:
September 16, 2021
Publication date:
August 11, 2022
Applicants:
Albert Einstein College of Medicine, Massachusetts Institute of Technology, IFO-Regina Elena Cancer Institute
Inventors:
John S. Condeelis, Sumanta Goswami, Frank Gertler, Paola Nistico
Abstract: Methods and kits for diagnosis, prognosis and treatment of metastatic tumors are provided where the metastatic tumor is characterized by changes in expression of +++, ++ and/or 11a variants of Mena.
Type:
Application
Filed:
July 27, 2017
Publication date:
November 23, 2017
Applicants:
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC., MASSACHUSETTS INSTITUTE OF TECHNOLOGY, IFO-REGINA ELENA CANCER INSTITUTE
Inventors:
John S. Condeelis, Sumanta Goswami, Frank Gertler, Paola Nistico
Abstract: Methods and kits for diagnosis, prognosis and treatment of metastatic tumors are provided where the metastatic tumor is characterized by changes in expression of +++, ++ and/or 11a variants of Mena.
Type:
Grant
Filed:
November 7, 2013
Date of Patent:
August 1, 2017
Assignees:
Albert Einstein College of Medicine, Inc., Massachusetts Institute of Technology, IFO-Regina Elena Cancer Institute
Inventors:
John S. Condeelis, Sumanta Goswami, Frank Gertler, Paola Nistico
Abstract: Methods and kits for diagnosis, prognosis and treatment of metastatic tumors are provided where the metastatic tumor is characterized by changes in expression of +++, ++ and/or 11a variants of Mena.
Type:
Application
Filed:
November 7, 2013
Publication date:
February 27, 2014
Applicants:
Albert Einstein College of Medicine of Yeshiva University, IFO-Regina Elena Cancer Institute, Massachusetts Institute of Technology
Inventors:
John S. Condeelis, Sumanta Goswami, Frank Gertler, Paola Nistico
Abstract: Methods and kits for diagnosis, prognosis and treatment of metastatic tumors are provided where the metastatic tumor is characterized by changes in expression of +++, ++ and/or 11a variants of Mena.
Type:
Grant
Filed:
July 31, 2009
Date of Patent:
December 10, 2013
Assignees:
Albert Einstein College of Medicine of Yeshiva University, Massachusetts Institute of Technology, IFO-Regina Elena Cancer Institute
Inventors:
John S. Condeelis, Sumanta Goswami, Frank Gertler, Paola Nisticò